Pediatrix Medical Group, Inc. (NYSE:MD) Receives $16.67 Average Price Target from Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six analysts that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $16.67.

MD has been the subject of a number of research analyst reports. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group reduced their price target on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Finally, Macquarie lifted their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th.

Institutional Trading of Pediatrix Medical Group

Large investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth approximately $169,000. SG Americas Securities LLC purchased a new position in shares of Pediatrix Medical Group in the fourth quarter worth $171,000. Principal Financial Group Inc. lifted its holdings in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Principal Financial Group Inc. now owns 551,924 shares of the company's stock worth $7,241,000 after buying an additional 38,306 shares in the last quarter. Deutsche Bank AG lifted its holdings in shares of Pediatrix Medical Group by 53.1% in the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock worth $971,000 after buying an additional 25,663 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Up 2.3%

NYSE MD traded up $0.31 during trading hours on Friday, reaching $13.85. 767,076 shares of the company's stock traded hands, compared to its average volume of 850,534. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The firm has a market cap of $1.19 billion, a PE ratio of -11.54, a PEG ratio of 1.74 and a beta of 1.26. The firm has a 50-day simple moving average of $13.67 and a 200 day simple moving average of $14.02. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Pediatrix Medical Group's revenue was down 7.4% on a year-over-year basis. During the same period last year, the company posted $0.20 EPS. Sell-side analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.